APSC 2018 Tentative Program · APSC 2018_Tentative Program Chair 1: Ming-Shien Wen (Taiwan) ... Peng-Sheng Chen ... Wen-Harn Pan (Taiwan) Chair 1:

APSC 2018_Tentative Program

Chair 1: Ming-Shien Wen (Taiwan)Chair 2: Gregory YH Lip (UK)10+5 Oral 1

Name10+5 Oral 2

Name10+5 Oral 3

Name10+5 Oral 4

Name10+5 Oral 5

Name10+5 Oral 6

Name

Chair 1: Shoei K. Stephen Huang (Taiwan)Chair 2: TBA

Left Atrial Appendage Occluder (LAAO) is Indicated for Stroke Prevention in Non-

valvular Atrial Fibrillation15 Protagonist: Chia-Ti Tsai (Taiwan)15 Antagonist: Gregory YH Lip (UK)5 Rebuttal5 Rebuttal5 Q&A

Ablation of Rotors Should be Performed in Rhythm Control of Atrial Fibrillation15 Protagonist: Yenn-Jiang Lin (Taiwan)15 Antagonist: Andrea Natale (USA)5 Rebuttal5 Rebuttal5 Q&A

Chair 1: Chia-Ti Tsai (Taiwan)Chair 2: Peng-Sheng Chen (USA)27+3 Neural Regulation for Arrhythmia Control

Peng-Sheng Chen (USA)17+3 NOS1AP Modulates Cardiac Repolarization and Risk of Sudden Cardiac Death

Kuan-Cheng Chang (Taiwan)17+3 Role of Oxidants and Metabolism in the Pathogenesis of Sudden Cardiac Death

Kai-Chien Yang (Taiwan)17+3 Genetic Functional Aspects Based on Genome-wide Study of Atrial Fibrillation

Patrick T. Ellinor (USA)

2Debate

15:30-17:003Basic and Translational Science

1_ArrhythmiasMay 18, 2018 (Friday)10:30-12:001Oral Session

13:30-15:00

Presented by APSC 2018

Chair 1: Tsu-Juey Wu (Taiwan)Chair 2: Khanchit Likittanasombat (Thailand)27+3 Use of High-resolution 3D Mapping System in Ablation of Atrial Tachyarrhythmias

after Interventional TherapyHiroshi Nakagawa (USA)

17+3 Use of Traditional 3D Mapping System in Ablation of Atrial Tachyarrhythmias after

Interventional TherapyAndrea Natale (USA)

17+3 Ablation of Complex Atrial Arrhythmias Associated with Congenital Heart Disease in

Pediatric PopulationMorio Shoda (Japan)

17+3 Tricks and Tips for Ablation of Unusual AV Nodal Reentrant TachycardiaMien-Cheng Chen (Taiwan)

Chair 1: Shih-Ann Chen (Taiwan)Chair 2: Andrea Natale (USA)27+3 Multiple Ablation Strategies for Paroxysmal and Persistent AF with PV and non-PV

TBA17+3 Application and Limitation of Cryoballoon for Pulmonary Vein Isolation

Chin-Pang Chan (Hong Kong)17+3 Non-vitamin K Antagonists (NOACs) for Stroke Prevention in non-valvular AF -

Discrepancy between the EAST and WESTGregory YH Lip (UK)

17+3 Practical Use of Various non-vitamin K Antagonists (NOACs): How to Select, Peri-

procedural Switch, and Reverse BleedingYi-Hsin Chan (Taiwan)

Chair 1: Kuan-Cheng Chang (Taiwan)Chair 2: Wataru Shimizu (Japan)27+3 Detection and Ablation of VT Substrate in Unstable Ventricular Tachyarrhythmias

Hiroshi Nakagawa (USA)17+3 Non-pharmacological Treatment of Brugada Syndrome

Koonlawee Nademanee (USA)17+3 Effective Control of Electrical Storm

TBA17+3 Transcutaneous Control of Ventricular Arrhythmias

Peng-Sheng Chen (USA)

13:30-15:006Management of Ventricular Arrhythmias and Sudden Cardiac Death

08:30-10:004Complex Supraventricular Tachycardia Ablation

10:30-12:005Management of Atrial Fibrillation

May 19, 2018 (Saturday)


Chair 1: Lian-Yu Lin (Taiwan)Chair 2: Chin-Pang Chan (Hong Kong)27+3 Newer Pacing Modalities and Permanent His Bundle Pacing for Improving Cardiac

Resynchronization TherapyChin-Pang Chan (Hong Kong)

17+3 Non-vascular ICD: Indications and Updates of Percutaneous and Wearable ICDChun-Chieh Wang (Taiwan)

17+3 Optimization of ICD Programing to Reduce Inappropriate ShocksJu-Yi Chen (Taiwan)

17+3 Usefulness and Safety of Remote Monitoring Device for CIED Follow-upSuneet Mittal (USA)

Chair 1: San-Jou Yeh (Taiwan)Chair 2: Khanchit Likittanasombat (Thailand)13+2 Nation-wide Studies of Sudden Cardiac Death in Thailand

Koonlawee Nademanee (USA)13+2 Nation-wide Studies of Sudden Cardiac Death in Japan

Wataru Shimizu (Japan)13+2 Outcomes of Out-of-hospital Cardiac Arrests Across 7 Countries in Asia

Matthew Huei-Ming Ma (Taiwan)13+2 Nation-wide Studies of Sudden Unexplained Death in Philippines

Giselle Gervacio (Philippines)13+2 Nation-wide Studies of Stroke Prevention and AF Ablation in Taiwan

Chern-En Chiang (Taiwan)13+2 Nation-wide Studies of Stroke Prevention and AF Ablation in India

Vijay Bohra (India)

May 20, 2018 (Sunday)08:30-10:008Nation-wide Studies from Asian Pacific Countries

15:30-17:007Cardiac Implantable Electronic Devices (CIED)


Chair 1: Takayuki Asahara (Japan)Chair 2: Hon-Kan Yip (Taiwan)18+3 Clinical Application of iPSC in Cardiovascular Diseases

Hung-Fat Tse (Hong Kong)18+3 Clinical Application of EPC in Cardiovascular Diseases

Takayuki Asahara (Japan)18+3 Current Therapeutic Reality of Endothelial Progenitor Cells for Patients with

Ischemic Cardiovascular DiseaseFan-Yen Lee (Taiwan)

18+3 Modification of Endothelial Progenitor Cells for Patients with Ischemic

Cardiovascular DiseasePo-Hsun Huang (Taiwan)

Chair 1: Patrick T. Ellinor (USA)Chair 2: Ling-Ping Lai (Taiwan)18+3 Genetics of Atrial Fibrillation: State of the Art in 2018

Patrick T. Ellinor (USA)18+3 Vaccination and Gene Therapy in Cardioavascular Diseases

Ryuichi Morishita (Japan)18+3 Genetics of Inherited Cardiac Arrhythmias

Jimmy Jyh-Ming Juang (Taiwan)18+3 Genetics of Young-onset Hypertension in Taiwan

Wen-Harn Pan (Taiwan)

Chair 1: Issei Komuro (Japan)Chair 2: Kou-Gi Shyu (Taiwan)18+3 Roles of Vascular and Metabolic Components in Cognitive Dysfunction of Alzheimer

Disease: Short- and Long-term Modification by Non-genetic Risk FactorsRyuichi Morishita (Japan)

18+3 Atherosclerotis Lesion and Intracellular Lipid Accumulation: Viewpoints from

MacrophagesPing-Yen Liu (Taiwan)

18+3 Application of Drug Delivery System Using Nanotechnologies (nanoDDS) in

Cardiovascular DiseasesKensuke Egashira (Japan)

18+3 Application of Nanotechnologies in the Diagnosis of Cardiovascular DiseasesChau-Chung Wu (Taiwan)

15:30-17:003New Horizons in Vascular Biology and Nanotechnologies in Cardiovascular Diseases (APSC

10:30-12:001Clinical Application of Stem Cell Therapy

13:30-15:002Genomic Medicine and Cardiovascular Diseases: Clinical and Therapeutic Implications

2_Basic ScienceMay 18, 2018 (Friday)


Chair 1: Hung-Fat Tse (Hong Kong)Chair 2: Pao-Hsien Chu (Taiwan)18+3 How to Unmask Concealed Long QT Patients?

Wataru Shimizu (Japan)18+3 Molecular Diagnosis in Cardiac Arrhythmia -Focus on Atrial Fibrillation

Hung-Fat Tse (Hong Kong)18+3 Fabry’s Disease: Strategies in Genetic Screening and Clinical Management

Dau-Ming Niu (Taiwan)18+3 Third Variable Effects in Cardiometabolic Genetics: Interaction, Mediation and

SuppressionYu-Lin Ko (Taiwan)

Chair 1: Yu Xin Li (Japan)Chair 2: Yen-Hung Lin (Taiwan)18+3 Aging and Cardiovascular Diseases: From Perspective of Heart Reprogramming,

Regeneration, and RejuvenationPatrick Ching-Ho Hsieh (Taiwan)

18+3 Aging and Cardiovascular Diseases: From Perspective of AtherosclerosisYu Xin Li (Japan)

18+3 Aging and Cardiovascular Diseases: From Perspective of Telomere and TelomeraseSem Hin Phan (USA)

18+3 Aging and Cardiovascular Diseases: From Perspective of Vascular BiologyShaw-Fang Yet (Taiwan)

Chair 1: Issei Komuro (Japan)Chair 2: Jaw-Wen Chen (Taiwan)18+3 PPAR Transcription Factors as Potential Drug Targets for the Treatment of Diabetes,

Dyslipidemia and Cardiovascular DiseaseBart Staels (France)

18+3 Genetics of Cardiometabolic DiseasePhilip S. Tsao (USA)

18+3 Adiponectin and Genetics of Metabolic SyndromeHsin-Bang Leu (Taiwan)

18+3 Emerging Role of Cell Regeneration in Cardiac DysfunctionIssei Komuro (Japan)

From Bench to Bedside - New Strategy for Cardiometabolic Disease

Molecular Diagnosis in Cardiovascular Disease

10:30-12:005Aging and Cardiovascular Diseases

13:30-15:006

May 19, 2018 (Saturday)08:30-10:004


Chair 1: Philip S. Tsao (USA)Chair 2: Wei-Jan Chen (Taiwan)25+3 Keynote

The Biological Clock and Time-of-day Incidence of Cardiovascular DiseaseBart Staels (France)

12+2 Oral 1Name

12+2 Oral 2Name

12+2 Oral 3Name

12+2 Oral 4Name

Chair 1: Pao-Hsien Chu (Taiwan)Chair 2: Po-Hsun Huang (Taiwan)25+3 Keynote

Vascular Regeneration beyond Endothelial Progenitors - An UpdateTakayuki Asahara (Japan)

12+2 Oral 1Name

12+2 Oral 2Name

12+2 Oral 3Name

12+2 Oral 4Name

8Oral Session 2

15:30-17:007Oral Session 1

May 20, 2018 (Sunday)08:30-10:00


Chair 1: Wen-Ter Lai (Taiwan)Chair 2: Marielle Scherrer-Crosbie (USA)25+5 Cardio-Oncology: A New Frontier in Medicine

Javid Moslehi (USA)25+5 Cardio-Oncology: The Scope of the Problem

Marielle Scherrer-Crosbie (USA)25+5 A Multidisciplinary Team Building: An Experience from Chemotherapy Associated

Peripheral Neuropathy Study in NCKUH in TaiwanJang-Yang Chang (Taiwan)

Chair 1: Lieng-Hsi Ling (Singapore)Chair 2: TBA20 Cardio-Oncology: Singapore Experiences

Lieng-Hsi Ling (Singapore)20 Cardio-Oncology: Taiwan Experiences

Li-Tzong Chen (Taiwan)20 Cardio-Oncology: Japan Experiences

Hiroshi Akazawa (Japan)20 Cardio-Oncology: Korea Experiences

Hak Jin Kim (Korea)10 Panel Discussion

Chair 1: Hak Jin Kim (Korea)Chair 2: Zhih-Cherng Chen (Taiwan)20 Case Sharing - Myocardial Dysfunction

Cardiologist: Wei-Ting Chang (Taiwan)Oncologist: Yin-Hsun Feng (Taiwan)

20 Case Sharing - Vascular DysfunctionCardiologist: Yen-Wen Liu (Taiwan)Oncologist: Chia-Jui Yen (Taiwan)

10 Rebuttal (5 mins each)10 Rebuttal (5 mins each)20 Case Sharing - Deep Vein Thrombosis

Cardiologist: Kai-Hung Cheng (Taiwan)Oncologist: Hui-Hua Hsiao (Taiwan)

10 Rebuttal (5 mins each)

Case Sharing: The Views from Cardiologists vs Oncologists

Cardio-Oncology, An Entangled Issue Between Cardiology and Oncology

13:30-15:002Cardio-Oncology in Asia

15:30-17:003

3_Cardio-oncologyMay 18, 2018 (Friday)10:30-12:001


Chair 1: Javid Moslehi (USA)Chair 2: Chi-Tai Kuo (Taiwan)15 Pathogensis of Chemotherapy Related Cardiotoxicity

Javid Moslehi (USA)15 How to Manage Cancer Patients with Ischemic Heart Disease?

Junya Ako (Japan)15 How to Manage Cancer Patients with Hypertension?

Yu-Chen Wang (Taiwan)15 How to Manage Cancer Patients with Heart Failure?

Masafumi Kitakaze (Japan)10 Panel Discussion

Chair 1: Ru San Tan (Singapore)Chair 2: Chih-Hui Chin (Taiwan)20 How Can We Use Biomarkers and Clinical Baseline Characteristics to Predict Cardiac

Toxicity?Kai-Hung Cheng (Taiwan)

20 How Can We Use Sonography to Predict Cardiac Toxicity?Hong-Wen Fei (China)

20 How Can We Use CT/MR to Predict Cardiac Toxicity?Ru San Tan (Singapore)

20 How Can We Use Genetics to Predict Cardiac Toxicity?Hiroshi Akazawa (Japan)

10 Panel Discussion

Chair 1: Hong-Wen Fei (China)Chair 2: Ning-I Yang (Taiwan)20 Unmet Needs in Cardio-Oncology

Marielle Scherrer-Crosbie (USA)20 Before, During and After Cancer Therapy - The Key Questions to Ask Our Patients

Yuh-Min Chen (Taiwan)20 Radiation Therapy: How to Mitigate Cardiotoxicity

Keng-Hsueh Lan (Taiwan)20 What Are the Cardiovascular Concerns in Immunotherapy?

Meng-Ting Peng (Taiwan)10 Panel Discussion

5Clinical, Imaging and Lab Parameters to Predict Cardiac Toxicity

13:30-15:006Cardio-Oncology: Future Perspectives

May 19, 2018 (Saturday)08:30-10:004Cancer and Cardiovascular Diseases

10:30-12:00


Chair 1: TBAChair 2: Junya Ako (Japan)20 Breast Cancer

Wei-Ting Chang (Taiwan)20 Hematological Malignancy

Shih-Peng Yeh (Taiwan)20 Lung Cancer

Chih-Hsin Yang (Taiwan)20 Colorectal Cancer

Johnson Lin (Taiwan)10 Panel Discussion

Chair 1: Ta-Chuan Hung (Taiwan)Chair 2: Kai-Hung Cheng (Taiwan)Time Topic 1

NameTime Topic 2

NameTime Topic 3

NameTime Topic 4

Name

7Organ Specific Cancer Treatment induced Cardiac Toxicity

May 20, 2018 (Sunday)08:30-10:008Oral Session

15:30-17:00


Chair 1: Jing Ping Sun (USA)Chair 2: TBAChair 3: Chung-Lieh Hung (Taiwan)Time Topic 1

NameTime Topic 2

NameTime Topic 3

NameTime Topic 4

NameTime Topic 5

NameTime Topic 6

Name

Chair 1: Ronald E. Cuyco (Philippines)Chair 2: Cheng-Wen Chiang (Taiwan)15+5 Role of Transesophageal Echocardiography (TEE) in Transcutaneous Aortic Valve

Intervention- Can We Do without TEE Guided?Kentaro Hayashida (Japan)

15+5 3D TEE for LAA OccluderAlex P.W. Lee (Hong Kong)

15+5 3D Echocardiography in Intervention for Congenital Heart DiseaseKai-Sheng Hsieh (Taiwan)

15+5 How to Image Repaired Tetralogy of Fallot?Tal Geva (USA)

Chair 1: Alex P.W. Lee (Hong Kong)Chair 2: Wei-Chuan Tsai (Taiwan)15+5 Imaging in Cardiorenal Syndrome: What the Nephrologist Needs?

Chi-Ting Su (Taiwan)15+5 Effects of Dialysis on Echocardiography Parameters

Ning-I Yang (Taiwan)15+5 Cardiovascular Imaging Study before Renal Transplantation

Ronald E. Cuyco (Philippines)15+5 Strain Imaging in Chronic Kidney Disease

Yen-Wen Liu (Taiwan)

2Cardiac Imaging in Structural Heart Disease and Cardiac Intervention

15:30-17:003Cardiovascular Imaging in Kidney Disease

4_Cardiovascular ImagingMay 18, 2018 (Friday)10:30-12:001Interesting Case Competition in Cardiovascular Imaging

13:30-15:00


Chair 1: Jong-Won Ha (Korea)Chair 2: Fen-Chiung Lin (Taiwan)15+5 From Tissue Doppler to Speckle Tracking

Jing Ping Sun (USA)15+5 From 2D to 3D Speckle Tracking Echocardiography

Masaaki Takeuchi (Japan)15+5 Speckle Tracking in Atrial Fibrillation

Ho-Ming Su (Taiwan)15+5 Speckle Tracking outside Left Ventricle

Wei-Chuan Tsai (Taiwan)

Chair 1: Jing Ping Sun (USA)Chair 2: TBA15+5 In Vivo Optical Coherence Tomography Visualization of Intraplague

Neovasculization at the Site of Coronary VasospasmKenichi Tsujita (Japan)

15+5 Noninvasive Detection of Coronary Vasospastic Angina using a Double-acquisition

Coronary CT Angiography Protocol in the Presence and Absence of an Intravenous

Nitrate: A Pilot StudyMoo Hyun Kim (Korea)

15+5 Oxidative Stress in Coronary Artery SpasmMing-Yow Hung (Taiwan)

15+5 Inflammation and Molecular Imaging in Vasospastic AnginaMing-Jui Hung (Taiwan)

Chair 1: Kenichi Tsujita (Japan)Chair 2: Ming-Jui Hung (Taiwan)15+5 Innovation in 3D Echocardiography

Masaaki Takeuchi (Japan)15+5 Myocardial Mechanics in Aging

Jing Ping Sun (USA)15+5 Recent Advance in Diastolic Stress Test

Jong-Won Ha (Korea)15+5 The Future of Cardiac Imaging in Congenital Heart Disease

Tal Geva (USA)

13:30-15:006Recent Advances in Cardiovascular Imaging

08:30-10:004Decades in Deformation Imaging

10:30-12:005Imaging for Coronary Spasm



Chair 1: Masaaki Takeuchi (Japan)Chair 2: Wen-Chung Yu (Taiwan)15+5 How to Use 2016 Guideline for Diastolic Function?

Hsin-Yueh Liang (Taiwan)15+5 How to Assess Left Ventricular Filling Pressure in Different Conditions?

Victor Chien-Chia Wu (Taiwan)15+5 How to Do Diastolic Stress Test and Its Clinical Implications?

Jong-Won Ha (Korea)15+5 How to Assess Diastolic Function by CT/MR Imaging?

Sony Hilal Wicaksono (Indonesia)

Chair 1: Hsin-Yueh Liang (Taiwan)Chair 2: Sony Hilal Wicaksono (Indonesia)Time Topic 1

NameTime Topic 2

NameTime Topic 3

NameTime Topic 4

NameTime Topic 5

NameTime Topic 6

Name


15:30-17:007How to Assess Diastolic Function?


May 18, 2018 (Friday)10:30-12:00

Chair 1: Chun-Chieh Wang (Taiwan)Chair 2: Chin-Pang Chan (Hong Kong)Panelist 1: Wen-Chin Ko (Taiwan)Panelist 2: Ta-Chuan Tuan (Taiwan)Panelist 3: Hsiang-Chiang Hsiao (Taiwan)Panelist 4: Chuen-Wang Chiou (Taiwan)Panelist 5: Chih-Chieh Yu (Taiwan)Demo 1 China Medical University Hospital (Taichung, Taiwan)

Case 1: Leadless Pacemaker ImplantationSuneet Mittal (USA)Kuo-Hung Lin (Taiwan)Jan-Yow Chen (Taiwan)

Panelist 1: Ching-Hui Huang (Taiwan)Panelist 2: Jen-Che Hsieh (Taiwan)Panelist 3: Kun-Tai Lee (Taiwan)Panelist 4: Dennis Wang (Australia)Panelist 5: TBADemo 2 National Taiwan University Hospital

Case 2: LAA OccluderChia-Ti Tsai (Taiwan)Jien-Jin Chen (Taiwan)Fu-Chun Chiu (Taiwan)

Lecture 1 Leadless Pacemaker: Current and Future Applications of Leadless Pacemaker15 Suneet Mittal (USA)

Lecture 2 LAA Occluder: Case Sharing and Real World Experience in Taiwan15 Li-Wei Lo (Taiwan)

13:30-17:00

Chair 1: Jen-Ping Chang (Taiwan)Chair 2: TBAPanelist 1: Shaw-Min Hou (Taiwan)Panelist 2: Chung-Yi Chang (Taiwan)Panelist 3: Pyng Jing Lin (Taiwan)Panelist 4: Chien-Sung Tsai (Taiwan)Panelist 5: TBAPanelist 6: TBAPanelist 7: Feng-Chun Tsai (Taiwan)Demo 1 National Taiwan University Hospital

Case 1: RoboticNai-Hsin Chi (Taiwan)

Demo 2 Far Eastern Memorial HospitalCase 1: EndoscopicKuan-Ming Chiu (Taiwan)

Demo 3 Taipei Veterans General HospitalCase 1: TEVARChun-Che Shih (Taiwan)

Lecture 1 (Please provide the topic)TBA

Lecture 2 (Please provide the topic)TBA

5_TaipeiLIVE

1TaipeiLIVE - Arrhythmia

2TaipeiLIVE - Cardiovasular Surgery


May 19, 2018 (Saturday)08:30-12:00

Chair 1: Juey-Jen Hwang (Taiwan)Chair 2: Jack Tan (Singapore)Chair 3: Chi-Jen Chang (Taiwan)Panelist 1: Khalida Soomro (Pakistan)Panelist 2: A.K.M. Mohibullah (Bungladesh)Panelist 3: Sok Chour (Cambodia)Panelist 4: Cheng-I Cheng (Taiwan)Panelist 5: Chi-Hung Huang (Taiwan)Panelist 6: Jung-Cheng Hsu (Taiwan)Panelist 7: Ye-Hsu Lu (Taiwan)Demo 1 National Taiwan University Hospital

Case 1: CTOSatoru Sumitsuji (Japan)Yi-Chih Wang (Taiwan)

Demo 2 MacKay Memorial HospitalCase 1: Complex PCI + iFFRSunao Nakamura (Japan)Cheng-Ting Tsai (Taiwan)Case 2: Complex PCI + iFFRSunao Nakamura (Japan)Cheng-Ting Tsai (Taiwan)

Chair 1: Jun-Jack Cheng (Taiwan)Chair 2: Kazushige Kadota (Japan)Chair 3: Huay Cheem Tan (Singapore)Panelist 1: Abdulla Shehab (UAE)Panelist 2: TBAPanelist 3: Shih-Chi Liu (Taiwan)Panelist 4: Tse-Min Lu (Taiwan)Panelist 5: Kuang-Te Wang (Taiwan)Panelist 6: Chen-Rong Tsao (Taiwan)Panelist 7: Meng-Huan Lei (Taiwan)

Demo 3 National Cheng Kung University HospitalCase 1: CTOMasahiko Ochiai (Japan)Cheng-Han Lee (Taiwan)

Lecture 1 Clinical Application of FFR or Update LM InterventionTBA

Lecture 2 PCI for CTO-Taiwan ExperienceShih-Chi Liu (Taiwan)

TaipeiLIVE - Adult Intervention I3


13:30-17:00

Chair 1: Chiung-Jen Wu (Taiwan)Chair 2: Hsuan-Li Huang (Taiwan)Panelist 1: Mungunchimeg Dagva (Mongolia)Panelist 2: Khalida Soomro (Pakistan)Panelist 3: Ping-Han Lo (Taiwan)Panelist 4: Wei-Chun Huang (Taiwan)Panelist 5: Lung-Ching Chen (Taiwan)Panelist 6: Chung-Ho Hsu (Taiwan)Panelist 7: Cheng-An Chiu (Taiwan)Panelist 8: Chun-Chi Chen(Taiwan)Panelist 9: TBAPanelist 10: Tsun-Jui Liu (Taiwan)Demo 1 National Taiwan University Hospital

Case 1: CTEPH-BPATakeshi Ogo (Japan)Yen-Hung Lin (Taiwan)Case 2: PADYoshimitsu Soga (Japan)Jen-Kuang Lee (Taiwan)

Demo 2 Taipei Veterans General HospitalCase 1: TAVIYing-Hwa Chen (Taiwan)Hsiao-Huang Chang (Taiwan)

Chair 1: Wen-Lieng Lee (Taiwan)Chair 2: Jian Ye (Canada)Panelist 1: TBAPanelist 2: Chiung-Zuan Chiu (Taiwan)Panelist 3: Shih-Hsien Sung (Taiwan)Panelist 4: TBAPanelist 5: Wei-Kung Tseng (Taiwan)Panelist 6: Zhih-Cherng Chen (Taiwan)Panelist 7: Hsu-Ping Wu (Taiwan)Panelist 8: Hsin-Fu Lee (Taiwan)

Demo 3 Cheng Hsin General HospitalCase 1: Mitral ClipWei-Hsian Yin (Taiwan)TBD

Lecture 1 Intervention for PAD: Kokura Data (題目自擬中)Yoshimitsu Soga (Japan)

Lecture 2 TBDJian Ye (Canada)

4TaipeiLIVE - Adult Intervention II


May 20, 2018 (Sunday)08:30-10:00

Chair 1: Mei-Hwan Wu (Taiwan)Chair 2: Shakeel Qureshi (UK)Panelist 1: Chun-Wei Lu (Taiwan)Panelist 2: Hung-Tao Chung (Taiwan)Panelist 3: Pi-Chang Lee (TaiwanPanelist 4: Zahid Amin (USA)Demo 1 National Taiwan University Hospital

Case 1: VSD OccluderJou-Kou Wang (Taiwan)Case 2: VSD OccluderJou-Kou Wang (Taiwan)

Lecture 1 What Interventionist Should Know about the VSD Anatomy?Shakeel Qureshi (UK)

Lecture 2 How to Avoid Complications during Transcatheter Closure of VSD?Zahid Amin (USA)

5TaipeiLIVE - Pediatric Intervention


Chair 1: I-Hui Wu (Taiwan)Chair 2: Kenji Minatoya (Japan)30 Open Repair of Aortopathy Involving Branches

Kenji Minatoya (Japan)20 TEVAR for Aortopathy Involving Branches Experience in Taiwan

Chun-Che Shih (Taiwan)20 TEVAR for Aortopathy Involving Branches Experience in Korea

Jae Won Lee (Korea)20 TEVAR for Aortopathy Involving Branches Experience in China

Liangwan Chen (China)

Chair 1: Nai-Hsin Chi (Taiwan)Chair 2: Hitoshi Yaku (Japan)20 Mitral Repair with Artificial Chordae

Hitoshi Yaku (Japan)20 Mitral Repair in Rheumatic Disease

TBA20 Slit Stent Technique for Ensuring the Correct Length of Artificial Chordae in Mitral

RepairJen-Ping Chang (Taiwan)

20 Pediatric Mitral RepairHajime Ichikawa (Japan)

10 Panel Discussion

Chair 1: Jen-Ping Chang (Taiwan)Chair 2: Ron-Bin Hsu (Taiwan)20 Valve-sparing Aortic Root Surgery

Takeo Tedoriya (Japan)20 Pediatric Aortic Valve Repair

Yves d'Udekem (Australia)20 Aortic Valve Reconstruction

Shigeyuki Ozaki (Japan)20 Rapid Deployment & Sutureless Aortic Valve Replacement

TBA10 Panel Discussion

15:30-17:007Aortic Valve Surgery

10:30-12:005Surgical Treatment of Aortopathy Involving Branches

13:30-15:006Mitral Valve Surgery

6-1_Cardiovascular SurgeryMay 19, 2018 (Saturday)


Chair 1: Chung-I Chang (Taiwan)Chair 2: Hajime Ichikawa (Japan)20 Surgical Treatment for Left Ventricular Outflow Tract Obstruction

Hajime Ichikawa (Japan)20 Management of Fontan Failure

Yih-Sharng Chen (Taiwan)20 Surgical Anatomy in Isomerism

Jeong-Wook Seo (Korea)20 Surgical Technique for Stage I and II Palliation in HLHS

Yves d'Udekem (Australia)10 Panel Discussion

Surgical Treatment in Complex Congenital Heart Diseases

May 20, 2018 (Sunday)08:30-10:008


Chair 1: Hung-Chi Lue (Taiwan)Chair 2: Yu-Mei Xie (China)10 Debate on VSD Closure: Transcatheter Closure is Better

Tin Nguyen Do (Vietnam)10 Debate on VSD Closure: Surgical Closure is Better

Hajime Ichikawa (Japan)3 Rebuttal (1)3 Rebuttal (2)9 Vote and Q & A10 Devices for Perimembranous VSD Closure: ADO I/ADO II

Ming-Tai Lin (Taiwan)10 Devices for Perimembranous VSD Closure: Occlutech VSD Device

Tin Nguyen Do (Vietnam)10 Devices for Perimembranous VSD Closure: Lifetech Device

Yu-Mei Xie (China)15 Long Term Outcome of Perimembranous VSD Closure

Yu-Mei Xie (China)10 Panel Discussion

Chair 1: Yun-Ching Fu (Taiwan)Chair 2: Ming-Ren Chen (Taiwan)20 Timing and Indication for Pulmonary Valve Replacement

Chun-An Chen (Taiwan)20 Transcatheter Replacement of Pulmonary Valve: What Valve?

Shakeel Qureshi (UK)20 Short-to Mid-term Results of Pulmonary Valve Replacement Using Venus P-valve

Worakan Promphan (Thailand)20 Long-term Outcomes of Melody Valve Replacement

TBA10 Panel Discussion

13:30-15:002Transcatheter Replacement of Pulmonary Valve

6-2_Pediatric CardiologyMay 18, 2018 (Friday)10:30-12:001Debate: Small to Moderate Perimembranous VSD


Chair 1: Jing-Ming Wu (Taiwan)Chair 2: Worakan Promphan (Thailand)15 Coarctation of Aorta Stenting: Indication and Timing

Shakeel Qureshi (UK)15 Coarctation of Aorta Stenting: Bare Stent or Cover Stent

Bharat Dalvi (India)15 Coarctation of the Aorta in Children: Ballon or Dilation or Stenting

Shakeel Qureshi (UK)15 PDA Stenting: Case Selection and Techniques

Ming-Tai Lin (Taiwan)15 Preventing Complications while Stenting Coarctation of the Aorta

Bharat Dalvi (India)15 Panel Discussion

Chair 1: Jiunn-Ren Wu (Taiwan)Chair 2: Satoshi Akagi (Japan)15 Management of Arrhythmia in Adult Congenital Heart Disease

Morio Shoda (Japan)15 Adult Congenital Heart Disease in Asia- Now and Future

Mei-Hwan Wu (Taiwan)15 Pre-pregnancy Counseling and Management of Women with CHD

Chun-Wei Lu (Taiwan)15 Advanced Management of Eisenmenger Syndrome

Satoshi Akagi (Japan)15 Pulmonary Vasodilator Therapy in Fontan Patients

Jou-Kou Wang (Taiwan)15 Panel Discussion

May 19, 2018 (Saturday)08:30-10:004Management of Adult Congenital Heart Disease

15:30-17:003Stenting of Coarctation of Aorta and PDA


Chair 1: TBAChair 2: Feras M. Bader (UAE)Time Topic 1

NameTime Topic 2

NameTime Topic 3

NameTime Topic 4

Name

Chair 1: Shing-Jong Lin (Taiwan)Chair 2: Jonathan Howlett (Canada)20 Overview in HF Guidelines

Martin Cowie (UK)20 Update of Pharmaco-therapy in Heart Failure

Piotr Ponikowski (Poland)20 Update of Cardiac Implantable Electronic Device Therapy in Heart Failure

Jin-Long Huang (Taiwan)20 Update of Mechanical Assist Device Therapy in Heart Failure

Christopher S. Hayward (Australia)

Chair 1: Hiroyuki Tsutsui (Japan)Chair 2: Wen-Jin Cherng (Taiwan)20 Aging as Co-morbidity of Heart Failure

Masafumi Kitakaze (Japan)20 Chronic Kidney Disease as Co-morbidity of Heart Failure

Shyh-Ming Chen (Taiwan)20 Chronic Obstructive Pulmonary Disease as Co-morbidity of Heart Failure

Hiroyuki Tsutsui (Japan)20 Metabolic Syndrome as A Co-morbidity of Heart Failure

TBA

15:30-17:003Co-morbidities of Heart Failure (TSOC-JHFS Joint Session)

10:30-12:001Oral Session

13:30-15:002Update on HF Guidelines

7_Congestive Heart FailureMay 18, 2018 (Friday)


Chair 1: Chi-Woon Kong (Taiwan)Chair 2: Martin Cowie (UK)20 Korea - KorAHF Registry

Eun Seok Jeon (Korea)20 Japan - ATTEND Registry

Naoki Sato (Japan)20 Taiwan - TSOC Systolic HF Registry

Wen-Jin Cherng (Taiwan)20 Singapore - Asian HF Registry

Jasper Tromp (Singapore)

Chair 1: Mark A. Richards (Singapore)Chair 2: Chii-Ming Lee (Taiwan)10 Promotion of Heart Failure Care in Australia

Christopher S. Hayward (Australlia)10 Promotion of Heart Failure Care in China

Jian Zhang (China)10 Promotion of Heart Failure Care in Malaysia

Houng Bang Liew (Malaysia)10 Promotion of Heart Failure Care in Korea

Kyu Hyung Ryu (Korea)10 Promotion of Heart Failure Care in Thailand

Teerapat Yingchoncharoen (Thailand)10 Promotion of Heart Failure Care in United Arab Emirates

Feras M. Bader (UAE)30 Discussion

Chair 1: Masafumi Kitakaze (Japan)Chair 2: Yen-Wen Wu (Taiwan)20 Overview of Acute Heart Failure

Naoki Sato (Japan)20 Biomarkers in Acute Heart Failure

Chao-Hung Wang (Taiwan)20 Why Trials Failed in Acute Heart Failure?

Piotr Ponikowski (Poland)20 Acute Exacerbations of Heart Failure, What is Next Stage?

Martin Cowie (UK)

Acute Heart Failure: From Dusk till Dawn

Asian Heart Failure Registry

10:30-12:005Promotion of Heart Failure Care in Asia-Pacific Countries

13:30-15:006

May 19, 2018 (Saturday)08:30-10:004


Chair 1: Charles Jia-Yin Hou (Taiwan)Chair 2: Christoph Maack (Germany)20 Things You Should Know about Neurohormone - How Do RAS & Neprilysin Inhibition

Co-work for Heart Failure Treatment?Jonathan Howlett (Canada)

20 Mineralocorticoid Receptor Antagonists in Heart FailureMark A. Richards (Singapore)

20 Treatment of Heart Failure in the ElderlyFeras M. Bader (UAE)

20 Treatment of Advanced Heart Failure - Mechanical Support vs. TransplantationYih-Sharng Chen (Taiwan)

Chair 1: Chun-Chieh Wang (Taiwan)Chair 2: Jasper Tromp (Singapore)Time Overview of Heart Failure with Preserved and Mid-range Ejection Fraction (HFpEF &

HFmrEF)Christoph Maack (Germany)

Time Diagnosis of HFpEFChii-Ming Lee (Taiwan)

Time Pathophysiology of HFpEFMark A. Richards (Singapore)

Time Treatment of HFpEFJonathan Howlett (Canada)

8Heart Failure with Preserved Ejection Fraction

15:30-17:007New Era of Heart Failure with Reduced Ejection Fraction

May 20, 2018 (Sunday)08:30-10:00


Chair 1: Liang-Miin Tsai (Taiwan)Chair 2: Gim-Hooi Choo (Malaysia)20 Complete Versus Incomplete Revascularization in Patients with Acute Myocardial

InfarctionJoo-Yong Hahn (Korea)

20 Application of CT/MR Imaging in ACSGim-Hooi Choo (Malaysia)

20 ACS Networking: Taiwan ExperienceWei-Chun Huang (Taiwan)

20 Roles of High Sensitivity Troponin in Early Triage and Management in ACSKenji Inoue (Japan)

Chair 1: Hung-Shun Lo (Taiwan)Chair 2: Mungunchimeg Dagva (Mongolia)20 Pain Control for ECMO Patients in CCU

TBA20 Ventilator-associated Events in CCU

Kuang-Yao Yang (Taiwan)20 Devastating Infections after Cardiovascular Surgery

Kuo-Sheng Liu (Taiwan)20 Early Rehabilitation in CCU

Ssu-Yuan Chen (Taiwan)

Chair 1: Chang-Chyi Lin (Taiwan)Chair 2: Kees H. Polderman (The Netherlands)20 Road Map To ICU Excellence

TBA20 Intelligent Mechanical Ventilators in Critical Care

Chin-Pyng Wu (Taiwan)20 New Strategy to MDRO (Multi-drug Resistant Organisms) in ICU

Jann-Tay Wang (Taiwan)20 Intelligent E-ICU with Family Centered Care

Huey-Wen Yien (Taiwan)

Future Impacts in Modern ICU

Advances in Acute Coronary Syndrome (ACS) Management

13:30-15:002CCU Issue Beside the Heart

15:30-17:003

8_Critical Care MedicineMay 18, 2018 (Friday)10:30-12:001


Chair 1: Matthew Huei-Ming Ma (Taiwan)Chair 2: Mayuki Aibiki (Japan)30 Review of the 2015 Guidelines, What We Got Right, What We Got Wrong?

Kees H. Polderman (The Netherlands)20 TTM: Optimal Cooling Methods

Mayuki Aibiki (Japan)20 TTM: Experience in Taiwan

Cheng-Hsueh Wu (Taiwan)20 Unmet Needs in Target Temperature Management

Wei-Tien Chang (Taiwan)

Chair 1: Nai-Kuan Chou (Taiwan)Chair 2: Takashi Akasaka (Japan)20 Ventilation in ECMO

Kenneth Palmer (Sweden)20 Mechanical Hemodynamic Support in High Risk PCI

Christian M. Spaulding (France)20 ECPR for Sudden Cardiac Death

Tetsuya Sakamoto (Japan)20 ECMO - Complication, Pitfall and Resolution

Nai-Kuan Chou (Taiwan)

Chair 1: Abdulla Shehab (UAE)Chair 2: Ju-Pin Pan (Taiwan)20 Community Efforts to Resuscitate Cardiac Arrest

Matthew Huei-Ming Ma (Taiwan)20 Public Access Defibrilation: Asian Impact

Tetsuya Sakamoto (Japan)20 Useful Markers for Predicting Survival and Neurological Outcome after Cardiac

Kees H. Polderman (The Netherlands)20 Is PCI Mandated for All Patients Resuscitated from Cardiac Arrest?

Christian M. Spaulding (France)

5Critical Mechanical Support

13:30-15:006How to Manage Cardiac Arrest

May 19, 2018 (Saturday)08:30-10:004Therapeutic Hypothermia and Targeted Temperature Management (TTM)

10:30-12:00


Chair 1: Wen-Jone Chen (Taiwan)Chair 2: Ross Freebairn (New Zealand)20 Medical Informatics and Intensive Care: Past, Now, and Future

Ross Freebairn (New Zealand)20 Impact of Circadian Rhythm and Dysrhythmia-from Basic Mechanism to Intensive

Care UnitKun Hu (USA)

20 Applications of Wearable/Portable Devices for Personalized Critical CareMen-Tzung Lo (Taiwan)

20 Dynamic Physiologic Signatures as Potential Biomarkers in Critical Care PatientsChen Lin (Taiwan)

Chair 1: Ming-Ren Chen (Taiwan)Chair 2: Ching-Tsuen Shen (Taiwan)15 VAD

Yves d'Udekem (Australia)15 ECMO

En-Ting Wu (Taiwan)10 Discussion

Debate: PDA in 1-2 kg Neonates15 Transcatheter Closure

Jieh-Neng Wang (Taiwan)15 Surgical Ligation

Shu-Chien Huang (Taiwan)Rebuttal

3 Surgical Ligation3 Transcatheter Closure10 Vote and Discussion4 Closing Remark

7Medical Informatics Advances in Critical Care Medicine

May 20, 2018 (Sunday)08:30-10:008Critical Care in Pediatric Cardiac Patients

15:30-17:00


Chair 1: Wayne Huey-Herng Sheu (Taiwan)Chair 2: Juliana Chan (Hong Kong)30 Keynote Lecture

Diabetes and Cardiovascular Complications in AsiaJuliana Chan (Hong Kong)

20 Global View of Type 2 DiabetesOliver Schnell (Germany)

20 Current Status of Type 2 Diabetes in JapanDaisuke Yabe (Japan)

20 Current Status of Type 2 Diabetes in TaiwanJung-Fu Chen (Taiwan)

Chair 1: Chin-Hsiao Tseng (Taiwan)Chair 2: Daisuke Yabe (Japan)40 Keynote Lecture

Cardiovascular Effects of Anti-diabetes Drugs : Focusing upon AsiansDaisuke Yabe (Japan)

25 Trends of Cardiovascular Complications in Subjects with Type 2 Diabetes in TaiwanChih-Cheng Hsu (Taiwan)

25 Anti-diabetic Medications and CancersChin-Hsiao Tseng (Taiwan)

Chair 1: Wai Kiat Ng (Malaysia)Chair 2: Yi-Heng Li (Taiwan)20 Insulin for Cardiologists: When, How, and What Dose?

Chih-Yuan Wang (Taiwan)20 Metformin for Cardiologists: Why and How?

Yi-Heng Li (Taiwan)20 Sulfonylurea for Cardiologists: What is Our Concerns?

Ting-Hsing Chao (Taiwan)20 Did the Heart Failure Issue Prohibit the Use of TZD?

Chung-Yin Chen (Taiwan)

2Using Big Data in Diabetes Research

15:30-17:003Anti-diabetic Agents: What Cardiologists Should Know? (Part I)

9_DiabetesMay 18, 2018 (Friday)10:30-12:001Type 2 Diabetes: A Silent Killer

13:30-15:00


Chair 1: Wei-Shiung Yang (Taiwan)Chair 2: Oliver Schnell (Germany)30 Keynote Lecture

Current Perspectives on Cardiovascular Outcome Trials in DiabetesOliver Schnell (Germany)

25 Incretin-based Therapy: What Have We Learned?Shih-Te Tu (Taiwan)

25 Is SGLT2 Inhibitor the Choice for All?Jeffrey Wayne Stephens (UK)

Chair 1: Tsung-Hsien Lin (Taiwan)Chair 2: Jayanthi Jayawardena (Sri Lanka)20 Diabetic Patients with CHD: Target and Drugs? (Diabetologist viewpoint)

Daisuke Yabe (Japan)20 Diabetic Patients with CHD: Target and Drugs? (Taiwan consensus)

Tsung-Hsien Lin (Taiwan)20 Diabetic Patients with Stroke: Target and Drugs? (Neurologist viewpoint)

Jiann-Shing Jeng (Taiwan)20 Diabetic Patients with Stroke: Target and Drugs? (Taiwan consensus)

Shih-Yi Lin (Taiwan)

Chair 1: Lee-Ming Chuang (Taiwan)Chair 2: Yadav Kumar Deo Bhatta (Nepal)20 Diabetic Patients with CKD: Target and Drugs? (Asia Pacific viewpoint)

Juliana Chan (Hong Kong)20 Diabetic Patients with CKD: Target and Drugs? (Taiwan consensus)

Shih-Yi Lin (Taiwan)20 Diabetic Patients with Heart Failure: Target and Drugs? (European viewpoint)

Oliver Schnell (Germany)20 Diabetic Patients with Heart Failure: Target and Drugs? (Taiwan consensus)

Chern-En Chiang (Taiwan)

13:30-15:006Management of Diabetes in Patients with Cardiovascular Diseases (Part II)

08:30-10:004Anti-diabetic Agents: What Cardiologists Should Know? (Part II)

10:30-12:005Management of Diabetes in Patients with Cardiovascular Diseases (Part I)



Chair 1: David Quek (Malaysia)Chair 2: Shoei-Shen Wang (Taiwan)20 Epidemiology

Tze-Fan Chao (Taiwan)20 Insulin Resistance and the Metabolic State in HF

Wei-Shiung Yang (Taiwan)20 Will Anti-diabetic Agents Induce HF?

Chung-Lieh Hung (Taiwan)20 Target of A1C and Treatment

Chern-En Chiang (Taiwan)

Chair 1: Daejung Kim (Korea)Chair 2: Shyh-Ming Shieh (Taiwan)Time Effect of Diabetes Share Care System in Taiwan

I-Te Lee (Taiwan)Time Diabetes Care System in Korea

Daejung Kim (Korea)Time Diabetes Care System in Thailand

Chaicharn Deerochanawong (Thailand)Time Diabetes Care System in Malaysia

Siew Pheng Chan (Malaysia)

May 20, 2018 (Sunday)08:30-10:008Multidiscipline Care for Patients with Diabetes

15:30-17:007Diabetes and Heart Failure: A Deadly Duet


Chair 1: Jyh-Hong Chen (Taiwan)Chair 2: Jorge A. Sison (Philippines)Time The Healthcare Burden of Hypertension in Asia

Yuqing Zhang (China)Time Hypertension and Cardiometabolic Risks in Asia

Jorge A. Sison (Philippines)Time Blood Pressure Targets and BP Control Rate in Asia

Peera Buranakitjaroen (Thailand)Time Barriers to Management of Hypertension: Asian Perspective

Kuo-Liong Chien (Taiwan)

Chair 1: Chen-Huan Chen (Taiwan)Chair 2: Yadav Kumar Deo Bhatta (Nepal)Time Taiwan Perspective

Kuo-Liong Chien (Taiwan)Time Japan Perspective

TBATime Singapore Perspective

Roger Sik Yin Foo (Singapore)Time Korean Perspective

Sungha Park (Korea)

Chair 1: Yung-Zu Tseng (Taiwan)Chair 2: Sungha Park (Korea)Time Unattended Automatic BP Monitoring

Paul K. Whelton (USA)Time Ambulatory BP Monitoring

Yuqing Zhang (China)Time Home BP Monitoring

Sungha Park (Korea)Time Central BP Monitoring

Hao-Min Cheng (Taiwan)

15:30-17:003Blood Pressure Measurement, Does It Matter?

10:30-12:001Challenges in the Management of Hypertension in Asia

13:30-15:002Management of Hypertension and Diabetes: Asian Perspective

10_HypertensionMay 18, 2018 (Friday)


Chair 1: Fu-Tien Chiang (Taiwan)Chair 2: Yumiko Oishi (Japan)Time Vascular Ageing and Endothelial Dysfunction

Chao-Yung Wang (Taiwan)Time Blood Pressure Variability, Central Blood Pressure and Cardiovascular Outcome

among the GeriatricsPai-Feng Hsu (Taiwan)

Time Interplay Between Heart, Brain and Kidney among the GeriatricsYumiko Oishi (Japan)

Time Diabesity and Vascular AgeingPing-Yen Liu (Taiwan)

Chair 1: Tzung-Dau Wang (Taiwan)Chair 2: Giuseppe Bianchi (Italy)Time Adducin, Ouabain, and Genome-oriented Hypertension Management

Giuseppe Bianchi (Italy)Time Salt-sensitive Hypertension in Asia: Prevalence, Genome, and Novel Therapy

Tzung-Dau Wang (Taiwan)Time Novel Aldosterone-related Therapy for Hypertension

Kang-Ling Wang (Taiwan)Time Telemedicine and Hypertension Management

Ying-Hsien Chen (Taiwan)

Chair 1: Cheng-Huang Su (Taiwan)Chair 2: Julian Chi Leung Wong (Singapore)Time Optimal Treatment of Elderly Hypertension with CKD in Asia, Should We Follow the

SPRINT Trial?Paul K. Whelton (USA)

Time Strategies for BP Control in Hypertensive Patients with ESRDChih-Jen Wu (Taiwan)

Time Update on Renal Artery Stenting for HypertensionJulian Chi Leung Wong (Singapore)

Time Asian Perspective on Renal Nerve DenervationYing-Hsiang Lee (Taiwan)

Hypertension and Kidney

Vascular Aging and Hemodynamics

10:30-12:005New Treatment Strategies for Hypertension

13:30-15:006

May 19, 2018 (Saturday)08:30-10:004


Chair 1: Chung-Sheng Lin (Taiwan)Chair 2: Genevieve M. Gabb (Australia)Time Hypertension Guideline

Giuseppe Mancia (Italy)Time Australia Hypertension Guideline

Genevieve M. Gabb (Australia)Time Korea Hypertension Guideline

Shung Chull Chae (Korea)Time Taiwan Hypertension Guideline

Kwo-Chang Ueng (Taiwan)

Chair 1: Cheng-Dao Tsai (Taiwan)Chair 2: Shung Chull Chae (Korea)Time Topic 1

NameTime Topic 2

NameTime Topic 3

NameTime Topic 4

NameTime Topic 4

NameTime Topic 5

Name

8Oral Session

15:30-17:007Hypertension Guideline Update

May 20, 2018 (Sunday)08:30-10:00


Chair 1: Chi-Ling Hang (Taiwan)Chair 2: Yoshimitsu Soga (Japan)Chair 3: Chun-Chi Chen (Taiwan)Chair 4: I-Chung Chen (Taiwan)Chair 5: Wei-Kung Tseng (Taiwan)20 Keep the Right Thing behind in Lower Limb Intervention: Evidence and Current

ConceptYoshimitsu Soga (Japan)

Time Topic 1Name

Time Topic 2Name

Time Topic 3Name

Time Topic 4Name

Chair 1: TBAChair 2: Sunao Nakamura (Japan)Chair 3: Yi-Chih Wang (Taiwan)Chair 4: Wen-Lieng Lee (Taiwan)Chair 5: A.K.M. Mohibullah (Bangladesh)20 Keynote

Management of Complication in PCISunao Nakamura (Japan)

Time Topic 1Name

Time Topic 2Name

Time Topic 3Name

Time Topic 4Name

Chair 1: Chuen-Den Tseng (Taiwan)Chair 2: Abdulla Shehab (UAE)Chair 3: Khalida Soomro (Pakistan)Chair 4: Tse-Min Lu (Taiwan)Chair 5: Chun-Ming Shih (Taiwan)20 IVUS-guided Complex PCI

Khalida Soomro (Pakistan)Time Topic 1

NameTime Topic 2

NameTime Topic 3

NameTime Topic 4

Name

Case Competition- Complex PCI

Case Competition of PAD and Structural Heart

13:30-15:002Case Competition- CTO

15:30-17:003

11_Ischemic Heart DiseaseMay 18, 2018 (Friday)10:30-12:001


Chair 1: TBAChair 2: TBATime Optimal Duration of Dual Antiplatelet Therapy for ACS

Yi-Heng Li (Taiwan)Time Evidence Supporting East Asian Paradox Regarding Antiplatelet Therapy in Patients

with ACSTBA

Time Efficacy and Safety of Prasugrel in Asian Patients with ACS and Patients Undergoing

Elective PCIShigeru Saito (Japan)

Time Ticagrelor for Post MI Disease TreatmentMarc Peter Bonaca (USA)

Chair 1: Alan Fong (Malaysia)Chair 2: Li-Jen Lin (Taiwan)Time Efficacy and Safety of NOAC in Asian Patients with Non-valvular AF Stroke

Chern-En Chiang (Taiwan)Time Anticoagulation / Antiplatelet Therapy in Patients with AF Undergoing PCI

Georg Nickenig (Germany)Time Dosing Strategy of NOAC in Patients with Non-valvular AF

Jan Steffel (Germany)Time Breaking Concept of Antithrombotic Strategies in Stable CAD

TBA

Chair 1: I-Chang Hsieh (Taiwan)Chair 2: Moo Hyun Kim (Korea)Time Role of iFR or FFR for Intermediate Lesion

Kuang-Te Wang (Taiwan)Time How to Evaluate the Vulnerable Plaque in Coronary Artery without Significant

Stenosis?Moo Hyun Kim (Korea)

Time Value of OCT in Coronary InterventionPo-Ming Ku (Taiwan)

Time Optimal Utilization of IVUS in Percutaneous Coronary InterventionSatoru Sumitsuji (Japan)

5When Antiplatelet Therapy Meets NOAC in Patients with or without Non-valvular Atrial

13:30-15:006Imaging Modalities in Coronary Intervention

May 19, 2018 (Saturday)08:30-10:004Optimizing Antiplatelet Therapy in Asian Patients with Acute Coronary Syndrome

10:30-12:00


Chair 1: Jun-Jack Cheng (Taiwan)Chair 2: TBATime Beyond Absorb, Can Other BRS Make Magic Happen?

TBATime Polymer-free Stent Design

TBATime Combo Stent Design

TBATime Magnesium BRS

TBA

Chair 1: Juey-Jen Hwang (Taiwan)Chair 2: TBATime Therapeutic Strategy of LM Intervention in Korea

Duk Woo Park (Korea)Time Therapeutic Strategy of LM Intervention in Japan

Sunao Nakamura (Japan)Time Current Status of TAVI in Korea

Hyo-Soo Kim (Korea)Time Current status of TAVI in Taiwan

Ying-Hwa Chen (Taiwan)Time Imaging in Coronary Intervention (KSC)

Seung-Ho Hur (Korea)Time Imaging in Coronary Intervention (APSC)

Yi-Chih Wang (Taiwan)

7Innovative & Advanced PCI Technology

May 20, 2018 (Sunday)08:30-10:008APSC Taiwan - KSC Joint Session

15:30-17:00


Chair 1:Chair 2:Time Topic 1

Name (Country)Time Topic 2



Name (Country)





Name (Country)





Name (Country)

2Sesson Title:

15:30-17:003Sesson Title:

12_MedTechMay 18, 2018 (Friday)10:30-12:001Sesson Title:

13:30-15:00


Chair 1: TBAChair 2: TBA40 Spectrum CT in Cardiology

TBA40 Automatic Intelligence in Ultrasound Imaging

TBA10 Q & A

Chair 1: TBAChair 2: TBA40 Image Guided Therapy

TBA40 Integrated Cardiology Information Solution: IntelliSpace Cardiovascular

TBA10 Q & A

Chair 1: TBAChair 2: TBA40 Progress in 2017: Workflow Making Changes

TBA40 Artificial Intelligence as the Pipeline of Computer Vision in Ultrasound Image

TBA10 Q & A

13:30-15:006TSOC: Aiming for AI- from the “Check-up your heart program” in 2017 Taipei Universiade

08:30-10:004Innovation and Integration of Information Technology in Cardiology (I)

10:30-12:005Innovation and Integration of Information Technology in Cardiology (II)



Chair 1: TBAChair 2: TBA40 Advanced Features in Echocardiography

TBA40 Cardiovascular Information Technology

TBA10 Q & A

Chair 1: TBAChair 2: TBATime Topic 1




Name (Country)

May 20, 2018 (Sunday)08:30-10:008Sesson Title

15:30-17:007Innovation and Integration of Information Technology in Cardiology (III)


Chair 1: Cheng-Ho Tsai (Taiwan)Chair 2: TBA15+5 Cardiovascular Disease Prevention in Thailand

Prasart Laothavorn (Thailand)15+5 Cardiovascular Disease Prevention in Taiwan

Ying-Wei Wang (Taiwan)15+5 Cardiovascular Disease Prevention in Australia

David Colquhoun (Australia)15+5 Cardiovascular Disease Prevention in Japan

Shizuya Yamashita (Japan)

Chair 1: Jiunn-Lee Lin (Taiwan)Chair 2: Seth Martin (USA)15+5 Risk Scores for Predicting CV Disease: What's Applicable in Asians?

Yeo Khung Keong (Singapore)15+5 Atherosclerosis Imaging to Assess Subclinical Disease

Michael Shapiro (USA)15+5 Global Risk Assessment (FRS, Reyenold's, PCE, etc.)

Seth Martin (USA)15+5 Risk Stratification of Coronary Artery Disease in Taiwan

Kuo-Liong Chien (Taiwan)

Chair 1: Koji Hasegawa (Japan)Chair 2: San-Jou Yeh (Taiwan)15+2 The Priority of Targets

Chau-Chung Wu (Taiwan)15+2 Strategy for Facing Aging Society

Koji Hasegawa (Japan)15+2 The Role of Omega-3 Fatty Acid

Pablo Perez-Martinez (Spain)15+2 Management of Residual Risks

Shizuya Yamashita (Japan)15+2 Targeting Anti-inflammation in Dyslipidemia

Masayuki Yoshida (Japan)

15:30-17:003Controversial Therapy for Dyslipidemia Management (ISCP Joint Session)

10:30-12:001Health Care Policy in Cardiovascular Disease Prevention

13:30-15:002Risk Stratification in Cardiovascular Diseases (ACC in Taiwan)

13_PreventionMay 18, 2018 (Friday)


Chair 1: TBAChair 2: Ta-Chen Su (Taiwan)15+5 Air Pollution and Cardiovascular Disease

Chang-Chuan Chan (Taiwan)15+5 Risk of Dust-haze in Cardiovascular Disease

TBA15+5 Endocrine Disrupting Chemicals and Cardiovascular Health

Ta-Chen Su (Taiwan)15+5 Cardiovascular Benefit of Pharmacological Treatments for Smoking Cessation

Koji Hasegawa (Japan)

Chair 1: Simon KH Wong (Hong Kong)Chair 2: Hung-I Yeh (Taiwan)15+2 Current Status and Management Strategy of Obesity in Western Countries

Robert J. Chilton (USA)15+2 Central Obesity and Body Mass Index: Impact on Cardiovascular Disease in Asia

Shao-Yuan Chuang (Taiwan)15+2 Bariatric Surgery Outcome, Fact or Fiction?

Simon KH Wong (Hong Kong)15+2 Pharmacological Intervention

Wei-Shiung Yang (Taiwan)15+2 Vascular Inflammation in Obesity

Masayuki Yoshida (Japan)

Chair 1: Kou-Gi Shyu (Taiwan)Chair 2: Philip Barter (Australia)15+5 PCSK9 Inhibition for High Risk ASCVD Patients

Kausik K. Ray (UK)15+5 CETP Inhibition in ASCVD

Philip Barter (Australia)15+5 Optimal Therapy for Familial Hyperlipidemia

Frederick J Raal (South Africa)15+5 Epigenetic Modification in ASCVD

Kausik K. Ray (UK)

New Era in Pharmacological Treatment of Atherosclerotic Disease

Environmental Pollution and Cardiovascular Disease

10:30-12:005Obesity as a Cardiovascular Disease Burden

13:30-15:006

May 19, 2018 (Saturday)08:30-10:004


Chair 1: Huei-Fong Hung (Taiwan)Chair 2: Wael Almahmeed (UAE)15+5 Cardiac Rehabilitation in Coronary Artery Disease

Maria Rosan Trani (Philippines)15+5 Cardiac Rehabilitation in Heart Failure

Bing-Hsiean Tzeng (Taiwan)15+5 Cardiac Evaluation of Athletes in Taipei 2017 Summer Universiade

Lung-Chun Lin (Taiwan)15+5 Benefit of Exercise on Cardiovascular Disease

Chi-Pang Wen (Taiwan)

Chair 1: Mohammad Saifur Rohman (Indonesia)Chair 2: Nai-Wei Hsu (Taiwan)13+2 Update of Dyslipidemia Guideline in Taiwan

Yi-Heng Li (Taiwan)18+2 Current Status of Lipid Control in (Australia)

Philip Barter (Australia)18+2 Current Status of Lipid Control in Indonesia

Mohammad Saifur Rohman (Indonesia)13+2 Is TG Important for Asians?

Chun-Yen Chen (Taiwan)18+2 FOURIER Trial: Clinical Implications for Asia Patiens

Eugene Yang (USA)

8Dyslipidemia Management in Asia

15:30-17:007Rehabilitation and Exercise

May 20, 2018 (Sunday)08:30-10:00


Chair 1: Susanna Proudman (Australia)Chair 2: Yih-Jer Wu (Taiwan)20 Contemporary Management of Pulmonary Arterial Hypertension Improves Outcome

Nick Kim (USA)20 Therapeutic Options for Childhood Pulmonary Hypertension Associated with

Congenital Heart DiseaseZen-Kong Dai (Taiwan)

20 Recent Update of Idiopathic/Heritable PAH Treatment in JapanTakeshi Ogo (Japan)

20 Breaking Barriers in PAH: The Oral ProstanoidsSusanna Proudman (Australia)

Chair 1: Yih-Jer Wu (Taiwan)Chair 2: Takeshi Ogo (Japan)20 Recent Update in CTEPH Diagnosis and Medical Therapy

Nick Kim (USA)20 Surgical Management for CTEPH

Michael Madani (USA)20 Balloon Pulmonary Angioplasty for CTEPH

Takeshi Ogo (Japan)20 Challenging Cases in CTEPH

Hsao-Hsu Hsu (Taiwan)

Chair 1: TBAChair 2: Kazufumi Nakamura (Japan)20 The Unsolved Problems in CTD Associated Pulmonary Hypertension

Susanna Proudman (Australia)20 Current perspective treatment of CTD associated PH in Japan

Yuichi Tamura (Japan)20 Treatment Strategy for CTD-PAH in Taiwan

Tsu-Yi Hsieh (Taiwan)20 Lung Transplant of PAH in Japan

Kazufumi Nakamura (Japan)

Pulmonary Hypertension in Connective Tissue Disease

Overview of Pulmonary Hypertension

13:30-15:002Recent Update in CTEPH Management

15:30-17:003

14_Miscellaneous: PAH, Structural Heart, Cardiomyopathy, Clinical TrialsMay 18, 2018 (Friday)10:30-12:001


Chair 1: Sofian Dato Paduka Hj Johar (Brunei)Chair 2: Yuan-Teh Lee (Taiwan)20 Too Little, Too Late: When Does TAVI Become Futile?

Mao-Hsin Lin (Taiwan)20 Mitral Valve Clips and Update

Shih-Hsien Sung (Taiwan)20 Tricuspid Valve Intervention

TBA20 Percutaneous Intervention of Pulmonary Valve

Worakan Promphan (Thailand)

Chair 1: Yu-Lin Ko (Taiwan)Chair 2: James Moon (UK)20 Fabry Disease, Focus on the Cardiac Variant in Taiwan

Wen-Chung Yu (Taiwan)20 Genetics of HOCM in Taiwan

Min-Ji Charng (Taiwan)20 Role of Cardiac MRI in the Management of Cardiomyopathy

James Moon (UK)20 Next Generation Sequencing in Cardiomyopathy

Jimmy Jyh-Ming Juang (Taiwan)

Chair 1: Jeroen Bax (Netherlands)Chair 2: TBA20 Myocardial Revascularisation

S. Windecker (alternative M. Haude or S. Price)10 Discussion

TBA20 Hypertension

Diederick Grobbee (alternative P. Dendale)10 Discussion

TBA20 Syncope

J. Camm (alternative H. Heidbuchel or C. Linde)10 Discussion

TBA

5Cardiomyopathy and Update

13:30-15:006ESC at APSC - Session 1: What Is New in ESC Guidelines 2018?

May 19, 2018 (Saturday)08:30-10:004Valvular Heart Diseases Intervention

10:30-12:00


Chair 1: Diederick Grobbee (Netherlands)Chair 2: TBA20 CAD

S. Windecker (alternative M. Haude or S. Price)10 Discussion

TBA20 Arrhythmias

J. Camm (alternative H. Heidbuchel or C. Linde)10 Discussion

TBA20 Heart Failure

Jeroen Bax (Netherlands)10 Discussion

TBA

Chair 1: Tsuei-Yuan Huang (Taiwan)Chair 2: Shoa-Lin Lin (Taiwan)15 Topic 1

TBD15 Topic 2

TBD15 Topic 3

TBD15 Topic 4

TBD15 Topic 5

TBD15 Topic 6

TBD

7ESC at APSC - Session 2: Highlights from the ESC


15:30-17:00


May 18, 2018 (Friday)10:30-12:00

Chair 1: 陳保羅 (台灣)Chair 2: 王繼光 (中國)15+2 混合型高脂血症的病因及治療策略選擇

陈红 (中國)15+2 中國高血壓現狀調查研究

李静 (中國)15+2 The Evaluation of Mobile Devices for Blood Pressure Measurement in Hypertension

Management王繼光 (中國)

15+2 Taiwan Lipid Guideline for High Risk Patients葉宏一 (台灣)

15+2 神經源性高血壓谢良地 (中國)

13:30-15:00

Chair 1: 鄭成泉 (台灣)Chair 2: TBA15+2 Ablation Treatment of Pulmonary Hypertension

陳紹良 (中國)15+2 C型利鈉肽治療心力衰竭的前景

李為民 (中國)15+2 中國心力衰竭治療現狀分析與對策

张健 (中國)15+2 台灣心臟衰竭中心的現況及對策

王兆弘 (台灣)15+2 先心病術後心律失常的處理

劉剛 (中國)

15:30-17:00

Chair 1: 常敏之 (台灣)Chair 2: 戴若竹 (中國)15+2 Current Status of China Chest Pain Center and Tasks

楊躍進 (中國)15+2 Treatment of STEMI in China: From Technology to System

周玉杰 (中國)15+2 DEB for In-stent Restenosis

張力 (中國)15+2 Prehospital Management of STEMI: Taiwan Experience

黃偉春 (台灣)15+2 ECMO在高危冠心病PCI中的應用體會

李国庆 (中國)

CAD

15_Asian Chinese Forum 2018 兩岸四地華人論壇

1Prevention

2CHF and Arrhythmia

3


May 19, 2018 (Saturday)08:30-10:00

Chair 1: 殷偉賢 (台灣)Chair 2: 謝宜璋 (台灣)Chair 3: 何奔 (中國)Chair 4: 王焱 (中國)Chair 5: 穆叶赛 (中國)Chair 6: 莫雅贞 (中國)Time 病例1

冠脈完全閉塞4 病例匯報

顧博明 (台灣)8 我會怎麼做

TBA8 我是如何做的

顧博明 (台灣)10 綜合討論Time 病例2

左主幹及分叉病變4 病例匯報

張俊杰 (中國)8 我會怎麼做

王志鴻 (台灣)8 我是如何做的

張俊杰 (中國)10 綜合討論Time 病例3

嚴重鈣化病灶4 病例匯報

李文領 (台灣)8 我會怎麼做

陳良龍 (中國)8 我是如何做的

李文領 (台灣)10 綜合討論

4How Would I Treat -1


10:30-12:00

Chair 1: 李文領 (台灣)Chair 2: 徐亚伟 (中國)Chair 3: 陳良龍 (中國)Chair 4: 李家紅 (中國)Chair 5: 方慶章 (台灣)Time 病例4

PCI合併症4 病例匯報

叶涛 (中國)8 我會怎麼做

郭風裕 (台灣)8 我是如何做的

叶涛 (中國)10 綜合討論Time 病例5

急性冠脈綜合症4 病例匯報

任勗龍 (台灣)8 我會怎麼做

張力 (中國)8 我是如何做的

任勗龍 (台灣)10 綜合討論Time 病例6

TAVR4 病例匯報

陳嬰華 (台灣)8 我會怎麼做

王建安 (中國)8 我是如何做的

陳嬰華 (台灣)10 綜合討論

5How Would I Treat -2


13:30-15:00

Chair 1: 王焱 (中國)Chair 2: 程俊傑 (台灣)15+2 Treatment and Prospect of Structural Heart Disease

王建安 (中國)15+2 Less Invasive Ventricular Enhancement System (Revivent-TC) for Treatment of Left

Ventricular Aneurysm王焱 (中國)

15+2 預測女性STEMI預後的評分系統-China Peace研究唐熠達 (中國)

15+2 介入影像之新進展廖智冠 (台灣)

15+2 定量血流分數(QFR)的研究與進展涂圣贤 (中國)

15:30-17:00

Chair 1: 王志鴻 (台灣)Chair 2: TBA15+2 Advance in MICRA Pacing System

蔣忠想 (香港)15+2 從左心耳封堵看卒中預防的發展趨勢

徐亚伟 (中國)15+2 The Application and Evaluation of Venous rh-BNP in STEMI-PCI Complicated with

Acute Left Heart Failure and Cardiac Shock傅向華 (中國)

15+2 Current Update of Drug-eluting Stents謝宜璋 (台灣)

15+2 Thinking about the Recovery of Sexual Life in CAD Patients from the Guide戴若竹 (中國)

May 20, 2018 (Sunday)08:30-10:00

Chair 1: 謝凱生 (台灣)Chair 2: 黃碧桃 (台灣)15+2 介入性治療的影像診斷

黃國英 (中國)15+2 VSD (介入性治療)

傅雲慶 (台灣)15+2 經導管關閉心室中隔缺損

TBA15+2 經皮卵圓孔封閉術的再思

刘文辉 (中國)15+2 經皮肺動胍瓣膜置換術

张戈军 (中國)

介入新進展-1

7介入新進展-2

8小兒介入-1 (謝凱生)

6


Documents

APSC 2018 Tentative Program · APSC 2018_Tentative Program Chair 1: Ming-Shien Wen (Taiwan) ... Peng-Sheng Chen ... Wen-Harn Pan (Taiwan) Chair 1: